Example: Heart Attack

Clinical Trials on Preleukemia

Total 5 results

  • NCT03066648
    Active, not recruiting
    Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDS
    Conditions: Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Preleukemia, Bone Marrow Diseases, Hematologic Diseases, Chronic Myelomonocytic Leukemia
  • NCT02158858
    Active, not recruiting
    A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
    Conditions: Myelofibrosis, Leukemia, Myelocytic, Acute, Myelodysplastic/Myeloproliferative Neoplasm, Myelodysplastic Syndrome (MDS), Preleukemia, Primary Myelofibrosis, Myeloproliferative Disorders, Bone Marrow Disease, Hematological Disease, Precancerous Conditions, Neoplasms, Leukemia, Neoplasms by Histologic Type, Essential Thrombocytosis
  • NCT04741945
    Recruiting
    Repurposing Metformin as a Leukemia-preventive Drug in CCUS and LR-MDS
    Conditions: Preleukemia, Myelodysplastic Syndromes, Cytopenia
  • NCT00943293
    Terminated
    Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies
    Conditions: Preleukemia, Myeloproliferative Disorders, Lymphoma, Myeloma, Graft Versus Host Disease
  • NCT00943592
    Completed
    Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
    Conditions: Advanced Hematologic Malignancies, Leukemia, Preleukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe